Nigel G. Kooreman

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Johanna W. Wilmink · 2 shared papers, 2025–2026 · strength 0.44
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
   • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
2. Judith de Vos‐Geelen · 2 shared papers, 2025–2026 · strength 0.44
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
   • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
3. Marjolein Y.V. Homs · 2 shared papers, 2025–2026 · strength 0.44
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
   • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
4. Simone Augustinus · 1 shared paper, 2026 · strength 0.24
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
5. Pauline A. J. Vissers · 1 shared paper, 2026 · strength 0.24
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
6. Merlijn U.J.E. Graus · 1 shared paper, 2026 · strength 0.24
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
7. Stefan A.W. Bouwense · 1 shared paper, 2026 · strength 0.24
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
8. Hanneke W.M. van Laarhoven · 1 shared paper, 2026 · strength 0.24
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
9. Aniek E. van Diepen · 1 shared paper, 2026 · strength 0.24
   • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
10. Anne M. Gehrels · 1 shared paper, 2026 · strength 0.24
    • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
11. Marc G. Besselink · 1 shared paper, 2026 · strength 0.24
    • Paper Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study. DOI 10.1097/j.pain.0000000000004059↗
12. Willem de Koning · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
13. Michail Doukas · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
14. Bas Groot Koerkamp · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
15. Jelle C. van Dongen · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
16. Ignace H. J. T. de Hingh · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
17. Gaby J. Strijk · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
18. Lodewijk A.A. Brosens · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
19. Casper H.J. van Eijck · 1 shared paper, 2025 · strength 0.20
    • Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
20. Noel F.C.C. de Miranda · 1 shared paper, 2021 · strength 0.19
    • Paper The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13225789↗
21. Ricki T. Krog · 1 shared paper, 2021 · strength 0.19
    • Paper The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13225789↗
22. Alexander L. Vahrmeijer · 1 shared paper, 2021 · strength 0.19
    • Paper The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers13225789↗
23. Edgar G. Engleman · 1 shared paper, 2021 · strength 0.11
    • Paper Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. DOI 10.1016/j.stemcr.2021.04.004↗
24. Aida Habtezion · 1 shared paper, 2021 · strength 0.11
    • Paper Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. DOI 10.1016/j.stemcr.2021.04.004↗
25. Joseph C. Wu · 1 shared paper, 2021 · strength 0.11
    • Paper Antitumor effects of iPSC-based cancer vaccine in pancreatic cancer. DOI 10.1016/j.stemcr.2021.04.004↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.